Metraipolis › archive › dc_bb674b4cde34

Neoadjuvant camrelizumab combined with radiotherapy as a chemotherapy-sparing approach for resectable locally advanced esophageal squamous cell carcinoma: a… — Europe PMC PMID:41803866

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41803866
DOI
10.1186/s12916-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-05T00:32:27.834Z
SHA-256 of the archived text
cdabe856f4d5fe2dc740057b906c1cd5cd6e752e52442c2323ddf7122f4501b1
Stable URL of this page
https://metraipolis.com/documento/dc_bb674b4cde34

How to cite

Neoadjuvant camrelizumab combined with radiotherapy as a chemotherapy-sparing approach for resectable locally advanced esophageal squamous cell carcinoma: a… — Europe PMC PMID:41803866 — Europe PMC (en), https://europepmc.org/article/MED/41803866 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb674b4cde34 (Metraipolis archive dc_bb674b4cde34, sha256 cdabe856f4d5fe2dc740057b906c1cd5cd6e752e52442c2323ddf7122f4501b1)
BibTeX
@misc{dcbb674b4cde34,
  title = {Neoadjuvant camrelizumab combined with radiotherapy as a chemotherapy-sparing approach for resectable locally advanced esophageal squamous cell carcinoma: a… — Europe PMC PMID:41803866},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41803866},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb674b4cde34; sha256 cdabe856f4d5fe2dc740057b906c1cd5cd6e752e52442c2323ddf7122f4501b1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41803866. Agents can read the archived copy with the MCP tool read_document.